Dr. Scott Gottlieb — a Westport resident — serves as President Trump’s commissioner of the Food and Drug Administration.
Yesterday, the New York Times assessed his tenure. The largely positive story begins:
Scott Gottlieb, the commissioner of the Food and Drug Administration, came to the job with a résumé straight out of the Trump administration’s playbook.
A millionaire with a libertarian bent, he made his money working for the industry he now regulates, and had investments in 20 health care companies whose products could come before the agency for approval. Pharmaceutical and medical device executives enthusiastically supported his nomination, while consumer and public health groups sounded the requisite alarms.
“Unprecedented financial entanglements,” complained Senator Patty Murray, Democrat of Washington, during his confirmation hearing.
Now, more than nine months after he was confirmed, Dr. Gottlieb has achieved something unusual among President Trump’s appointees: He has quieted some skeptics, while also managing to keep industry supporters content and the president on his side. He has done so by making moves to protect public health while also offering rewards to industry — double plays that have some willing to give him a second look.
Click here to read the full piece.